Processa Pharmaceuticals Inc (NAS:PCSA) Stock News, Headlines & Updates
Processa Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jul 01, 2025
Processa Pharmaceuticals Provides Portfolio and Business Update
Marketwired • 8:00am
Jun 30, 2025
PCSA: HC Wainwright & Co. Adjusts Price Target While Maintaining Buy Rating | PCSA Stock News
GuruFocus News • 6:30am
Jun 17, 2025
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
Marketwired • 12:00pm
Processa Pharmaceuticals (PCSA) Announces Public Offering Pricing | PCSA Stock News
GuruFocus News • 11:45am
Processa Pharmaceuticals (PCSA) Sets Public Offering Price at $0.25 per Share | PCSA Stock News
GuruFocus News • 11:45am
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering | PCSA Stock News
GuruFocus News • 11:45am
Processa Pharmaceuticals (PCSA) Enters Licensing Agreement for Gastroparesis Treatment | PCSA Stock News
GuruFocus News • 8:18am
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
Marketwired • 8:00am
Jun 13, 2025
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025 | PCSA Stock News
GuruFocus News • 7:18am
Processa Pharmaceuticals (PCSA) Prepares for Strategic Insights at BIO Convention 2025 | PCSA Stock News
GuruFocus News • 7:17am
PCSA Stock Placement by H.C. Wainwright & Co. | PCSA Stock News
GuruFocus News • 7:17am
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
Marketwired • 7:00am
May 30, 2025
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News
GuruFocus News • 8:17am
Processa Pharmaceuticals (PCSA) Highlights Cancer Drug Advances at ASCO 2025 | PCSA Stock News
GuruFocus News • 8:16am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news